These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7017016)

  • 21. EFFECT OF PARTIALLY PURIFIED STREPTOCOCCAL M PROTEIN ON THE IN VITRO PHAGOCYTOSIS OF STREPTOCOCCUS PYOGENES.
    DOMINGUE GJ; PIERCE WA
    J Bacteriol; 1965 Mar; 89(3):583-8. PubMed ID: 14275650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular aspects of the phagocytosis resistance of group A streptococci.
    Manjula BN
    Eur J Epidemiol; 1988 Sep; 4(3):289-300. PubMed ID: 3053236
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci.
    Miörner H; Johansson G; Kronvall G
    Infect Immun; 1983 Jan; 39(1):336-43. PubMed ID: 6337099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils.
    Staali L; Mörgelin M; Björck L; Tapper H
    Cell Microbiol; 2003 Apr; 5(4):253-65. PubMed ID: 12675683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in surface characteristics of group A streptococci].
    Savoia D; Vulcano F; Martinotti MG
    G Batteriol Virol Immunol; 1987; 80(1-12):3-13. PubMed ID: 3334316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci.
    Whitnack E; Beachey EH
    J Bacteriol; 1985 Oct; 164(1):350-8. PubMed ID: 3900042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M(+) group a streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes.
    DeMaster E; Schnitzler N; Cheng Q; Cleary P
    Infect Immun; 2002 Jan; 70(1):350-9. PubMed ID: 11748201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface characteristics of group A streptococci with and without M-protein.
    Miörner H; Havlícek J; Kronvall G
    Acta Pathol Microbiol Immunol Scand B; 1984 Feb; 92(1):23-30. PubMed ID: 6424406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of blood serum components on the growth, biochemical and biological properties of streptococcus].
    Savel'ev EP; Bitko SA; Dynga LO; Shmakova ZF; Smirnova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):6-10. PubMed ID: 2660478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative differences in specific binding of fibrinogen fragment D by M-positive and M-negative group-A streptococci.
    Schmidt KH; Gerlach D; Kühnemund O; Köhler W
    Med Microbiol Immunol; 1984; 173(3):145-53. PubMed ID: 6094999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
    Peterson PK; Schmeling D; Cleary PP; Wilkinson BJ; Kim Y; Quie PG
    J Infect Dis; 1979 May; 139(5):575-85. PubMed ID: 374652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
    Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spa contributes to the virulence of type 18 group A streptococci.
    McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
    Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.
    Feito MJ; Sánchez A; Oliver MA; Pérez-Caballero D; Rodríguez de Córdoba S; Albertí S; Rojo JM
    Mol Immunol; 2007 Jul; 44(14):3571-9. PubMed ID: 17467801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group A streptococci: evaluation of in vitro resistance to two macrolides.
    Millesimo M; Savoia D
    Microbios; 1995; 82(332):141-7. PubMed ID: 7630322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.
    Whitnack E; Bisno AL; Beachey EH
    Infect Immun; 1981 Mar; 31(3):985-91. PubMed ID: 7014469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
    Whitnack E; Beachey EH
    J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors.
    Wexler DE; Nelson RD; Cleary PP
    Infect Immun; 1983 Jan; 39(1):239-46. PubMed ID: 6337096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.